patient_nbr
int64 135
190M
| Patient context and readmission decision formatted for training
stringlengths 1.99k
2.15k
|
---|---|
7,490,601 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 530. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
838,854 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 531. The secondary diagnosis (coded as first three digits of ICD9): 250.82. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
5,702,373 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 74. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 35. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 285. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Down. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
69,973,740 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 787. The secondary diagnosis (coded as first three digits of ICD9): 198. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
61,462,863 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 64. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.22. The secondary diagnosis (coded as first three digits of ICD9): 491. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
67,518,999 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 38. Additional secondary diagnosis (coded as first three digits of ICD9): 585. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
38,724,426 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 45. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): V42. Additional secondary diagnosis (coded as first three digits of ICD9): 250.4. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
14,515,371 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 26. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 4. The primary diagnosis (coded as first three digits of ICD9): 530. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
5,620,536 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
2,408,922 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 433. The secondary diagnosis (coded as first three digits of ICD9): 292. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
36,686,808 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 23. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
830,205 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
5,565,897 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 518. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Up. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
633,906 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [90-100). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 61. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 578. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
352,377 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 250.52. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:<30 days. </s> |
5,287,950 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 996. Additional secondary diagnosis (coded as first three digits of ICD9): 682. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
6,127,722 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 41. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 296. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
2,071,701 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 76. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.12. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): V11. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
13,320 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 58. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 787. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
463,230 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 56. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 276. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 558. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
3,397,761 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 466. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
1,723,572 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 79. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.02. The secondary diagnosis (coded as first three digits of ICD9): 135. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: Norm. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
1,697,436 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 84. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 573. The secondary diagnosis (coded as first three digits of ICD9): 577. Additional secondary diagnosis (coded as first three digits of ICD9): E932. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
73,286,937 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 577. The secondary diagnosis (coded as first three digits of ICD9): 571. Additional secondary diagnosis (coded as first three digits of ICD9): 250.01. Number of diagnosis: 3. Max_glu_serum test result: >200. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
508,824 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Surgery-Neuro. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 722. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
6,656,679 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 780. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
87,847,776 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Other. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 71. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 820. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): E885. Number of diagnosis: 5. Max_glu_serum test result: >200. A1Cresult test result: >7. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
92,840,139 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Down. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
102,364,812 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
59,859,657 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
7,440,732 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 10. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
9,295,110 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 49. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
23,179,356 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 571. The secondary diagnosis (coded as first three digits of ICD9): 303. Additional secondary diagnosis (coded as first three digits of ICD9): 571. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
4,747,986 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.7. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
2,600,469 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Transfer from a hospital. Number of days between admission and discharge: 11. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 75. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 33. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 197. The secondary diagnosis (coded as first three digits of ICD9): 486. Additional secondary diagnosis (coded as first three digits of ICD9): 162. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: Down. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
8,760,915 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
95,439,834 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 250.41. Additional secondary diagnosis (coded as first three digits of ICD9): 403. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
3,217,491 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 6. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.03. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
47,412,873 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 62. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 491. The secondary diagnosis (coded as first three digits of ICD9): 162. Additional secondary diagnosis (coded as first three digits of ICD9): 198. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
352,377 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 780. The secondary diagnosis (coded as first three digits of ICD9): 304. Additional secondary diagnosis (coded as first three digits of ICD9): 250.51. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
3,105,513 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 3. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 272. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
3,000,240 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 13. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 492. The secondary diagnosis (coded as first three digits of ICD9): 440. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
348,120 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 68. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 32. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
3,198,834 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Psychiatry. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 296. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Up. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
65,392,893 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 198. The secondary diagnosis (coded as first three digits of ICD9): 117. Additional secondary diagnosis (coded as first three digits of ICD9): 198. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
105,366,150 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
74,020,698 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 220. The secondary diagnosis (coded as first three digits of ICD9): 154. Additional secondary diagnosis (coded as first three digits of ICD9): 218. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
439,470 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 433. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250.6. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
22,783,734 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 66. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 486. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
3,457,683 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 305. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
13,590 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 17. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
4,472,064 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 516. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 303. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
9,416,952 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 786. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
3,381,201 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 566. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 41. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
83,268,891 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Physician Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 210. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 3. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
2,020,491 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 50. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 412. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Down. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
7,308,234 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 599. The secondary diagnosis (coded as first three digits of ICD9): 707. Additional secondary diagnosis (coded as first three digits of ICD9): 250.02. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
317,934 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 562. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 401. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
27,926,721 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
81,353,088 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [20-30). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 81. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 9. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 5. The primary diagnosis (coded as first three digits of ICD9): 486. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 250.42. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
67,825,269 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [30-40). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 51. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 2. The primary diagnosis (coded as first three digits of ICD9): 250.6. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 571. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
8,127,882 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 28. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): V57. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 5. Max_glu_serum test result: >200. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
111,353,067 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 24. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 250.02. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
875,979 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 63. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 5. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 250.12. The secondary diagnosis (coded as first three digits of ICD9): 276. Additional secondary diagnosis (coded as first three digits of ICD9): 599. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
362,610 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 59. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 425. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
80,019,189 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 424. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
901,332 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 34. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 808. The secondary diagnosis (coded as first three digits of ICD9): 852. Additional secondary diagnosis (coded as first three digits of ICD9): 276. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Down. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: Steady. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
56,222,487 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: ?. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 12. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 31. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 997. The secondary diagnosis (coded as first three digits of ICD9): 599. Additional secondary diagnosis (coded as first three digits of ICD9): V42. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
2,407,023 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 996. Additional secondary diagnosis (coded as first three digits of ICD9): 414. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
42,499,845 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to home with home health service. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 77. Number of procedures (other than lab tests) performed during the encounter: 5. Number of medications administered during the encounter: 15. Number of outpatient visits of the patient in the year preceding the encounter: 3. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 398. Additional secondary diagnosis (coded as first three digits of ICD9): 402. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
98,992,197 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 410. The secondary diagnosis (coded as first three digits of ICD9): 398. Additional secondary diagnosis (coded as first three digits of ICD9): 396. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
35,259,498 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 7. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 562. The secondary diagnosis (coded as first three digits of ICD9): 560. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 3. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
1,896,381 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [80-90). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Not Mapped. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 37. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 22. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 996. Additional secondary diagnosis (coded as first three digits of ICD9): V14. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
389,862 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 40. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 427. Additional secondary diagnosis (coded as first three digits of ICD9): 272. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Up. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
4,103,964 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 10. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 57. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 250.83. Additional secondary diagnosis (coded as first three digits of ICD9): 458. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
8,325,099 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 36. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
45,703,377 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Expired. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 50. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 518. Additional secondary diagnosis (coded as first three digits of ICD9): 427. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
1,054,494 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: Cardiology. Number of lab tests performed during the encounter: 65. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 733. Additional secondary diagnosis (coded as first three digits of ICD9): 784. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Up. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
1,665,054 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: Surgery-General. Number of lab tests performed during the encounter: 48. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 682. The secondary diagnosis (coded as first three digits of ICD9): 496. Additional secondary diagnosis (coded as first three digits of ICD9): 305. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
45,655,695 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [40-50). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to another short term hospital. admission_source: Emergency Room. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 47. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 572. The secondary diagnosis (coded as first three digits of ICD9): 287. Additional secondary diagnosis (coded as first three digits of ICD9): 570. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:<30 days. </s> |
76,433,292 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 19. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 18. Number of outpatient visits of the patient in the year preceding the encounter: 1. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 403. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: Steady. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
69,023,016 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 78. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 43. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 401. Additional secondary diagnosis (coded as first three digits of ICD9): 428. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: Steady. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
3,051,027 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ObstetricsandGynecology. Number of lab tests performed during the encounter: 22. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 19. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 250.03. Additional secondary diagnosis (coded as first three digits of ICD9): 654. Number of diagnosis: 6. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
55,111,707 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Elective. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 39. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 27. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 197. The secondary diagnosis (coded as first three digits of ICD9): 196. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
4,951,944 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Male. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged/transferred to another type of inpatient care institution. admission_source: Transfer from a hospital. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 38. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 434. The secondary diagnosis (coded as first three digits of ICD9): 729. Additional secondary diagnosis (coded as first three digits of ICD9): 433. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: Steady. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
1,061,811 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Emergency Room. Number of days between admission and discharge: 7. Payer code: ?. Medical speciality of the admitting physician: InternalMedicine. Number of lab tests performed during the encounter: 53. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 21. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 780. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: >8. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
64,052,667 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 40. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 8. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 286. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): E934. Number of diagnosis: 5. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
84,595,104 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [40-50). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 9. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 31. Number of procedures (other than lab tests) performed during the encounter: 4. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 996. The secondary diagnosis (coded as first three digits of ICD9): 573. Additional secondary diagnosis (coded as first three digits of ICD9): 255. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
28,982,313 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [10-20). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 4. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 52. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 518. The secondary diagnosis (coded as first three digits of ICD9): 250.11. Additional secondary diagnosis (coded as first three digits of ICD9): 244. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
90,056,529 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Asian. Gender: Male. Age: [60-70). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 23. Number of procedures (other than lab tests) performed during the encounter: 6. Number of medications administered during the encounter: 23. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 885. The secondary diagnosis (coded as first three digits of ICD9): 816. Additional secondary diagnosis (coded as first three digits of ICD9): 882. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
65,418,831 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Not Mapped. Number of days between admission and discharge: 2. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 42. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 12. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 786. The secondary diagnosis (coded as first three digits of ICD9): 414. Additional secondary diagnosis (coded as first three digits of ICD9): 250. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: Steady. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
91,228,698 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Urgent. discharge disposition: Discharged to home. admission_source: Transfer from a hospital. Number of days between admission and discharge: 1. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 3. Number of medications administered during the encounter: 14. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 411. Additional secondary diagnosis (coded as first three digits of ICD9): 278. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: Steady. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
4,204,035 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 6. Payer code: ?. Medical speciality of the admitting physician: Orthopedics-Reconstructive. Number of lab tests performed during the encounter: 46. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 20. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 958. The secondary diagnosis (coded as first three digits of ICD9): 250.6. Additional secondary diagnosis (coded as first three digits of ICD9): 41. Number of diagnosis: 9. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
60,354,486 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged to home. admission_source: Clinic Referral. Number of days between admission and discharge: 14. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 43. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 11. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 296. The secondary diagnosis (coded as first three digits of ICD9): 250. Additional secondary diagnosis (coded as first three digits of ICD9): 564. Number of diagnosis: 3. Max_glu_serum test result: Norm. A1Cresult test result: >7. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:>30 days. </s> |
5,118,912 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [60-70). Weight (pounds): ?. admission type: nan. discharge disposition: Not Mapped. admission_source: Physician Referral. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Pulmonology. Number of lab tests performed during the encounter: 70. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 9. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 428. The secondary diagnosis (coded as first three digits of ICD9): 162. Additional secondary diagnosis (coded as first three digits of ICD9): 496. Number of diagnosis: 5. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
80,845,353 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [70-80). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 54. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 414. The secondary diagnosis (coded as first three digits of ICD9): 250.01. Additional secondary diagnosis (coded as first three digits of ICD9): 411. Number of diagnosis: 7. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |
96,830,199 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [20-30). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 11. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 1. The primary diagnosis (coded as first three digits of ICD9): 661. The secondary diagnosis (coded as first three digits of ICD9): 648. Additional secondary diagnosis (coded as first three digits of ICD9): V27. Number of diagnosis: 4. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Up. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
96,901,416 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Male. Age: [80-90). Weight (pounds): ?. admission type: nan. discharge disposition: Discharged/transferred to home with home health service. admission_source: Physician Referral. Number of days between admission and discharge: 8. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 29. Number of procedures (other than lab tests) performed during the encounter: 2. Number of medications administered during the encounter: 13. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): V57. The secondary diagnosis (coded as first three digits of ICD9): 428. Additional secondary diagnosis (coded as first three digits of ICD9): 682. Number of diagnosis: 5. Max_glu_serum test result: Norm. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: No. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: No'. [/INST] Classification:NO. </s> |
105,956,433 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: AfricanAmerican. Gender: Female. Age: [30-40). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged to home. admission_source: Emergency Room. Number of days between admission and discharge: 3. Payer code: ?. Medical speciality of the admitting physician: ?. Number of lab tests performed during the encounter: 67. Number of procedures (other than lab tests) performed during the encounter: 0. Number of medications administered during the encounter: 10. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 1. Number of inpatient visits of the patient in the year preceding the encounter: 0. The primary diagnosis (coded as first three digits of ICD9): 648. The secondary diagnosis (coded as first three digits of ICD9): 642. Additional secondary diagnosis (coded as first three digits of ICD9): 648. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Steady. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: No. Any diabetic medicine prescribed: Yes'. [/INST] Classification:NO. </s> |
115,196,778 | <s>[INST] Based on the patient context provided, classify the readmission risk as 'NO', '>30 days', or '<30 days':
'Patient's context
Race: Caucasian. Gender: Female. Age: [50-60). Weight (pounds): ?. admission type: Emergency. discharge disposition: Discharged/transferred to SNF. admission_source: Emergency Room. Number of days between admission and discharge: 5. Payer code: ?. Medical speciality of the admitting physician: Family/GeneralPractice. Number of lab tests performed during the encounter: 44. Number of procedures (other than lab tests) performed during the encounter: 1. Number of medications administered during the encounter: 16. Number of outpatient visits of the patient in the year preceding the encounter: 0. Number of emergency visits of the patient in the year preceding the encounter: 0. Number of inpatient visits of the patient in the year preceding the encounter: 3. The primary diagnosis (coded as first three digits of ICD9): 427. The secondary diagnosis (coded as first three digits of ICD9): 585. Additional secondary diagnosis (coded as first three digits of ICD9): 250.41. Number of diagnosis: 8. Max_glu_serum test result: None. A1Cresult test result: None. Metformin dosage change: No. Repaglinide dosage change: No. nateglinide dosage change: No. chlorpropamide dosage change: No. glimepiride dosage change: No. acetohexamide dosage change: No. glipizide dosage change: No. glyburide dosage change: No. tolbutamide dosage change: No. pioglitazone dosage change: No. rosiglitazone dosage change: No. acarbose dosage change: No. miglitol dosage change: No. troglitazone dosage change: No. tolazamide dosage change: No. examide dosage change: No. citoglipton dosage change: No. insulin dosage change: Down. glyburide-metformin dosage change: No. glipizide-metformin dosage change: No. glimepiride-pioglitazone dosage change: No. metformin-rosiglitazone dosage change: No. metformin-pioglitazone dosage change: No. Change in diabetic medication dosage: Ch. Any diabetic medicine prescribed: Yes'. [/INST] Classification:>30 days. </s> |